[Interventional strategies in hypertension management]

Area of Science:

• Cardiology
• Nephrology
• Neurology

Context:

• Severe treatment-resistant hypertension management has seen the rise of invasive therapies.
• Renal denervation and baroreceptor activation therapy target the autonomic nervous system for blood pressure control.

Purpose:

• To review the efficacy and challenges of current invasive treatments for resistant hypertension.
• To discuss the importance of rigorous study design, such as double-blind trials, in evaluating these therapies.
• To explore potential future directions and patient selection criteria for interventions.

Summary:

• Renal denervation, initially promising, showed no significant blood pressure reduction in a key double-blind study, highlighting the need for improved techniques and patient selection.
• Baroreceptor activation therapy, though less studied, demonstrated a modest blood pressure reduction in a double-blind trial.
• Novel approaches like arteriovenous shunts and brainstem stimulation are under investigation for hypertension management.

Impact:

• Emphasizes the critical role of well-designed clinical trials in validating novel hypertension treatments.
• Suggests that renal denervation and baroreceptor activation therapy may still hold potential with further refinement and appropriate patient selection.
• Highlights the ongoing search for effective interventions for difficult-to-treat hypertension, including novel device-based therapies.